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ABSTRACT 
In this study, a Quality by Design (QbD) approach was used to identify the effect of 
formulation parameters in a twin screw wet extrusion granulation process for the 
manufacturing of ibuprofen (IBU) granules with increased dissolution rates. A fractional 
factorial Design of Experiment (DoE) was used to investigate the effect of the excipient 
composition, binder amount and liquid to solid (L/S) ratio (independent variables) on drug 
dissolution rates, median particle size diameter and specific surface area (dependent 
variables). The intra-granular addition of the binder in inorganic/polymer blends processed 
with ethanol as granulating liquids facilitated the formation of granules at various particle 
sizes.  DoE regression analysis showed that all formulation parameters affect the dependent 
variables significantly.  The enhanced dissolution rates were attributed not only to the IBU 
particle size reduction and adsorption in the porous inorganic network but also to the high 
specific surface area of the produced granules. Dynamic vapour sorption showed increased 
water absorption for granules with small particle size distribution and high specific surface 
area.  
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1. Introduction 
In the recent years twin–screw extrusion granulation (TSG) has attracted significant 
interest for the development of a variety of oral solid dosage forms such as granules, tablets 
or capsules in a continuous manufacturing manner. TSG approaches have been introduced as 
an alternative approach for the passage from batch processing to continuous manufacturing in 
the pharmaceutical industry. Although there are several reported studies, extrusion 
granulation is still in its infancy and further work is required to fully understand the 
technology (Schimdt et al., 2016).  In a recent study, Thompson et al highlighted the 
influence of various processing and formulation parameters on the granulation process. 
According to Thompson et al., and Djuric et al., scaling up of extrusion granulation is not a 
straightforward exercise and the mechanisms within the process need to be better understood 
(Thompson, 2015; Djuric et al., 2009).  
The two major extrusion granulation approaches are a) wet granulation where the 
granulating liquid, with or without the addition of binders, is pumped into the screw zones 
and b) hot melt granulation which uses a molten binder to effectively bind the drug and the 
polymers (Weatherley et al., 2013).  Both process can effectively manufacture high quality 
granules for immediate or sustained drug release, however, both processes also present a 
number of drawbacks. For example, wet granulation requires a drying step for water removal 
that is time consuming while hot granulation uses relatively high barrel temperatures varying 
from 60-100
o
C.  
An in-depth study was presented by Vercruysse et al., using a six-segmented fluid bed 
dryer of the ConsiGma™-25 system comprising of a continuous twin screw granulation and 
drying system (Vercruysse et al., 2015a).  By running the system for 1 h the authors 
evaluated the effect of process outcomes, granule properties and tablet quality attributes. The 
torque and barrel wall temperatures were stabilized after 30 min performance while the tablet 
properties were adequate when comparing two ConsiGma systems (-1 and -25). Other studies 
have highlighted the impact of screw configuration on the particle size distribution, where 
conveying elements produced wide multimodal size distributions, while kneading elements 
have found to narrow the size of agglomerates (Vercruysse et al., 2015b; Meng et al., 2016).  
The delivery of the binder in the powder blend or in the granulating liquid has a tremendous 
effect on the obtained granule quality (Saleh et al., 2015; Batra et al., 2016). The 
incorporation of binders, which are blended in the powder mix, resulted in longer residence 
times and higher torque, but also produced narrower particle size distribution, spherical 
granules and better binder distribution. In contrast, Fonteyne et al. demonstrated that 
excellent binder distribution can be obtained by both when the binder is added in the dry 
blend or when it is added within the granulation liquid (Fonteyne et al., 2014). In the case of 
melt granulation, low melting binders create stronger granules and the binder molecular 
weight appeared to have no effect in the process (Weatherley et al., 2013).  More recently the 
use of a foamed binder solution led to the formation of more uniform wetted mass and larger 
granule growth (Rocca et al., 2015; Thompson et al., 2012). 
Meier et al., (2016) showed that the feeder performance in conjunction to the screw 
design influences the granule quality for highly drug loaded formulations and the obtained 
granule particle size requires detailed knowledge of the feeding systems (Meier et al., 2016). 
The formulation composition is an aspect that clearly should be taken in account (Meier et 
al., 2015; Keen et al., 2015; Vanhoorne et al., 2016) where binary or ternary premix blends 
affect the granule quality as well as the drug dissolution rates. 
In order to understand the granulation process and the mechanisms involved during 
material processing, in – line and off – line process analytical tools (PAT) have been 
implemented to provide valuable insights (Fonteyne et al., 2016; Monteyne et al., 2016a,  
2016b; Kumar et al., 2014; Vercruysse et al., 2014; Chablani et al., 2011; Maniruzzaman et 
al., 2015; Kumar et al., 2014). Near infrared (NIR) probes were used to measure the granules 
moisture content in comparison to Karl Fisher and loss of drying moisture measurements. In 
addition, NIR was used to understand the mixing and distribution of granulating liquid. The 
coupling of Raman mapping with twin – screw granulation provides information of the 
polymorph transitions and allows mapping of the drug distribution in the granular 
agglomerates. Similarly, the binder mixing efficiency and distribution was identified through 
hyperspectral coherent anti-Stokes Raman scattering (CARS) microscopy. The use of high-
speed camera enabled also the visualization of the particle size distribution and shape in real 
time.  
The purpose of the current study was to investigate the effect of formulation 
parameters such as excipient composition ratio, binder amount and L/S ratio on the granule 
formation of a water insoluble drug when processed with organic granulating liquids. Dry 
blends of inorganic excipients such as anhydrous dicalcium phosphate with a low molecular 
weight hydrohyxpropylmethyl cellulose (HPMC) grade were processed for first time with 
ethanolic granulating liquid.  
 
 
2. Materials and methods 
2.1 Materials 
Ibuprofen (IBU) was purchased from FarmaShino Pharmaceuticals Co. Ltd., 
(Nanjing, China) and dibasic calcium phosphate anhydrous (DCPA, Fujicalin®, DCPA) was 
kindly donated by Fuji Chemical Industries Co., Ltd. (Japan). Hydroxypropyl methylcellulose 
based polymer Pharmacoat 603 (HPMC) was kindly donated by Shin Etsu, Japan. 
Polyethylyne glycole 2000 (PEG) and ethanol (95%, 190 proof) were purchased from Sigma 
Aldrich (Gillingham, UK). All solvents used were of analytical grade and used as received. 
2.2 Twin screw granulation and DOE analysis 
Extrusion granulation studies were conducted using a twin-screw extruder (EuroLab 
16, Thermo Fisher, Duisburg, Germany) with a length/diameter (L/D) ratio of 40). A 
configuration with three kneading zones at 30
o
/40
o
 /60
o
, 60
o
 and 90
o
 angles respectively was 
used for all the granulation trials. The IBU formulations were thoroughly mixed in a Turbula 
(TF2, Basel, Switzerland) mixer of 1 Kg batches for 10 min each, prior to the extrusion 
process. During granulation, dry blends of the drug, polymer, inorganic carrier and the binder 
PEG were fed into the extruder with a volumetric feeder (Brabender, Duisburg, Germany) at 
1 kg/h feed rate while the screw rate was set at 100 rpm under ambient temperature.  A 
peristaltic pump, plunged in close proximity to the extruder’s feeding opening, supplied the 
granulating liquid (ethanol) at a constant rate. The “as made” extruded granules were dried in 
an oven (Memmert UF30, UK) at 30
o
C for 2h then further micronized through a cutter mill 
(Retsch, Germany) with a 250 µm fitted mesh.  
For the QbD approach a Design of Experiment (DoE) was introduced by using Fusion 
One software (DoE Fusion One
TM
, California, USA). A response surface fractional factorial 
design (2
3
+3=11) in randomized order with three centre points was designed with three 
independent and three dependant variables. The drug loading was kept constant (40%) where 
the DCPA/Polymer ratio (0.33 – 2.0), binder amount (5 – 12%) and L/S ratio (0.25 – 4.0) 
were set as independent variable. The drug release rate, the median particle size distribution 
(D50) and specific surface area (SSA) were defined as the dependant variables. 
 
2.3 Particle size analysis 
The particle size distribution of the extruded granules was determined using a 
Mastersizer 2000 laser diffraction analyser (Malvern Instruments, UK) with a dry powder 
sample dispersion accessory (Scirocco 2000). Samples were processed with a pressure at 0.5 
bars and a vibration feed rate of 50% in triplicate. The software analysis provided the d(10) 
d(50) and d(90) granular particle size values which are the geometric median particle size 
particle diameters at 10 and 90% of the cumulative volume distribution, respectively.  
 
2.4 Scanning electron microscopy (SEM) 
SEM images of the extruded IBU granules were captured using a cold-cathode field-
emission gun scanning electron microscope (Hitachi SU8030 FEG-SEM, Tokyo, Japan) with 
30 mm2 Ultra-Dry window and Noran 7 software. The samples were glued using adhesive 
carbon tape on sample tabs and coated with carbon (Edwards 306 high vacuum carbon 
evaporation) prior to the analysis. The accelerating voltage was set at 8 kV.  
 
2.5 X-ray powder diffraction (XRPD) 
XRPD was used to determine the solid state of bulk materials, physical mixtures and 
extruded granules using a Bruker D8 Advance (Karlsruhe, Germany) in theta-theta mode. For 
the study purposes a Cu anode at 40kV and 40Ma, parallel beam Goebel mirror, 0.2 mm exit 
slit, LynxEye Position Sensitive Detector with 3° opening (LynxIris at 6.5 mm) and sample 
rotation at 15 rpm were used. Each sample was scanned from 2 to 60° 2 with a step size of 
0.02° 2 and a counting time of 0.1 seconds per step; 176 channels active on the PSD making 
a total counting time of 35.2 seconds per step. The positions of the diffraction peaks for both 
the bulk, physical mixture and granulated products were identified using EVA phase analysis 
software (Bruker, Karlsruhe, Germany). TOPAS V4.2 structural analysis software (Bruker, 
Karlsruhe, Germany), was utilized to estimate the amount of amorphous content present in 
the granules. Crystal structural data of for Ibuprofen was taken from the Cambridge structural 
database (CSD) (REFCODE: JEKNOC10) and used as a standard alongside our granules. 
TOPAS scales the peaks to the standard and redistributes the rest which allows us to estimate 
the percentage amount of amorphous material present in the sample (Freer et al., 1993).  
 
2.6 Differential scanning calorimetry (DSC) study 
A Mettler-Toledo 823e (Greifensee, Switzerland) differential scanning calorimeter 
(DSC) was used to conduct thermal analysis of the bulk materials, physical mixtures and 
extruded granules. Typical samples of 3-5 mg were placed in sealed aluminium pans with 
pierced lids.  The samples were heated at 10°C/min from 0°C to 220°C under dry nitrogen 
atmosphere and reheated at the same heating rate. 
2.7 Dynamic vapour sorption (DVS) analysis 
Moisture sorption and desorption of the IBU loaded granules were determined via an 
automated gravimetric dynamic vapour sorption (DVS) analyser, Advantage-1 (Surface 
Measurements Systems Ltd, UK). All samples were equilibrated at 0% RH for 5 min to 
record the dry and reference mass prior to the exposition of the samples to the following 
relative humidity (% RH) profile: 0 to 100% in 20% steps and the reverse for desorption at 
25.0±0.1°C and 40±0.1°C. At each stage, prior to the change of the humidity, the sample 
mass allowed to reach equilibrium defined as dm/dt=0.002 mg/min over 10 min, before the 
RH was changed. A total gas flow 200 sccm was maintained throughout the study. The 
amount of water uptake was calculated as percentage of weight change compared to the dry 
initial mass. 
 
2.8 In vitro dissolution study 
In vitro drug dissolution studies were carried out in 900 ml of both 0.1 M HCl (pH 
1.2) and 0.2 M dihydrogen-sodium-orthophosphate (pH adjusted with NaOH to 6.8) for 2 hr 
using a Varian 705 DS dissolution paddle apparatus (Varian Inc. North Carolina, US) at 100 
rpm. The dissolution bath and the vessels were equilibrated at 37 ± 0.5°C. Samples (5ml) 
were withdrawn at predetermined time intervals for HPLC assay. All dissolution studies were 
performed in triplicate. 
 
2.9 HPLC analysis  
 The drug release was determined by HPLC analysis using an Agilent Technologies 
system 1200 series with a HYCHROME S50DS2-4889 (5 µm x 150 mm x 4mm) column. 
The mobile phase consisted of acetonitrile/water/phosphoric acid (65/35/0.2 v/v) while the 
flow rate and the wavelength were set at 1.5 ml/min and 214 nm. The calibration curve 
plotted with concentrations varying from 10 µg /ml to 50 µg/ml and 20 µl injection volumes. 
The IBU retention times varied from 2.5 – 3.0 min.  
 
3. Results and discussion 
3.1 Evaluation of extrusion granulation process 
The QbD is well defined by regulatory authorities and involves “A systematic 
approach to development that begins with predefined objectives and emphasizes product and 
process understanding and process control, based on sound science and quality risk 
management”. However, we need to clarify that the current QbD approach is limited to the 
process understanding and mainly to the effect of the formulation parameters on the extrusion 
granulation. The objectives included the formation of IBU granules with increase dissolution 
rates, uniform particle size distribution and excellent granule flowability.  
One of the most important aspects in extrusion granulation is the appropriate selection 
of the drug carriers as different polymer grades (viscosity and substitution degree) are 
directly related to the quality of granules and the drug dissolution rates (Vanhoorne et al., 
2016). Although HPMC grades with a higher molecular weight have been utilized for 
sustained release formulations before, in this study we used HPMC substitution type 2910 
with a higher degree of hydroxypropyl substituents, which has a low molecular weight and 
low viscosity. Because HPMC is insoluble in primary alcohols, no swelling occurred and 
hence low torque values were observed. There is only one study by Djuric and Kleinebudde 
where inorganic excipients such as DCPA are used to study the scale up of wet granulation 
processing (Djuric and Kleinebudde, 2010).  However, the authors used a low-quality grade 
of DCPA (Di-CaFos) with high cohesiveness and poor flowability. In this study, we 
introduced a spray-dried DCPA grade with excellent flowing properties, spherical shape, high 
surface area and porosity. As described above, for the purposes of the study the screw 
configuration consisted of three kneading blocks where disks offset at different angles 
varying at 30
o
, 60
o
 and 90
o
 (Fig.1).  Previous work has shown that kneading elements narrow 
the particle size of the granules (Vercruysse et al., 2015b; Meng et al., 2016) and particularly 
the 90
o
 configurations increase agglomeration resulting in fewer fines and small particles 
(Thompson and Sun, 2010).    
The various PEG binder amounts were blended intra-granularly with the dry premix 
without being dissolved in the ethanolic granulating liquid to facilitate narrower granule size 
distribution with spherical shape and thus better flowability. In addition, DCPA has shown 
better granulating performance when processed with organic solvents. PEG was chosen as the 
binder due to its low molecular weight. PEG is extremely hydrophilic and hydrophilic binders 
have been shown to affect binder – polymer interactions (e.g. HPMC) and allow for faster 
dissolution rates (Tan et al., 2014).  Finally, the screw speed and feed rate were kept constant 
at 100 rpm and 1Kg/h respectively, hence the process throughput, in order to reduce the 
number of granulation variables. There are contradictory reports related to the screw speed 
and throughput increase (Kumar et al., 2014; Vercruysse et al., 2012; Tan et al., 2011) on the 
obtained particle size distribution and the formation of large agglomerates.  Thus, the effect 
of processing parameters would require a completely separate study and further 
experimentation. For the same reasons the IBU amount was kept at 40% for all formulations 
throughout the granulation process. 
As shown in Table 1 the DoE the independent variables included the DCPA/Polymer 
ratio (A), the binder amount (B) and the liquid/solid (C) ratio on the granulation process 
while the drug dissolution rate, the median particle size (D50) and the specific surface area 
(SSA) were identified as the dependent variables.  The software regression analysis (Table 
S1, Suppl. Material) showed that all independent variables have a significant effect on IBU 
dissolution rates (<0.05).  A two – way interaction between A/B, A/C and B/C showed also 
significant effect on dissolution suggesting a complex granulation process. These results are 
quite different to a similar study conducted by Maniruzzaman et al., where deionized water 
was used as granulating liquid and only the excipients ratio influenced the drug dissolution 
rates. Similarly, DCPA/HPMC, PEG amount and L/S have a significant effect on the granule 
particle size distribution (p<0.05). The latter is in good agreement with other extrusion 
granulation studies (Maniruzzaman et al., 2015; Dhenge et al., 2012). Finally, the granule 
specific surface area was affected significantly by the DCPA/Polymer ratio and the binder 
(PEG %) amounts.  
The contour plots in Fig. 2 show the response surface plots for the three dependent 
variables. The implementation and analysis of a response surface fractional factorial DoE 
with a reduced number of runs helped to identify the effects of the selected independent 
variables and identify those settings for granules of optimized quality.  
 
3.2 Particle morphology and distribution 
SEM analysis investigated the size and the morphology of the bulk materials and 
obtained granules.  Fig. 3 shows needle shaped crystal morphology for bulk unprocessed IBU 
while all extruded formulations appear as granular agglomerates with almost spherical shape. 
For some extruded formulations, SEM images show the presence of minuscule particles 
varying for 10 – 50 m. Furthermore, no drug crystals can be seen in the granules suggesting 
adsorption in the porous DCPA network (104 m
2
/g) and consequently particle size reduction 
of the drug substance through the granulation process. The average particle size of all 
extruded formulations (except F6) is much smaller compered to bulk IBU which supports this 
assumption.  It is likely that IBU was partly dissolved by ethanol which facilitated its particle 
size reduction. 
Additional investigations were conducted by using laser diffraction analysis to 
identify the particle size distribution of the various granules. As shown in Fig. 4 several of the 
granulated batches presented monomodal distribution while for most formulations the size 
distribution is bimodal. A careful observation of the laser diffraction analysis shows that 
bimodal distributions are related to either an increased amount of fine or large agglomerates. 
Table 1 shows a wide variation for the d(50) particle size diameter of all DOE experiments 
ranging from 188.0 – 1033m. The smaller particle size distributions correspond to higher 
SSA values, which can affect the granule hydration and consequently the IBU dissolution 
profiles. Furthermore, from Table 1 it can be observed that monomodal particle size 
distributions are affected by the DCPA/polymer (1:1) and binder amounts (8-12%).  As 
shown in Table S2 (Suppl. Material) most of the granulated formulations presented excellent 
flowability which was attributed to the presence of DCPA and the obtained quality of the 
granules (Dhenge et al., 2012).  
 
3.3 X-ray powder diffraction (XRPD) 
X-ray analysis of the bulk materials and extruded granules was carried out to 
investigate the physical state of IBU during processing. Fig. 5 (inset) shows distinct intensity 
peaks corresponding to IBU at 6.03
o
, 12.09
o
, 16.48
o
, 17.55
o
, 18.75
o
, 20.02
o
, 22.13
o
, 24.47
o
, 
24.99
o
 2θ position and PEG at 19.01o and 23.49o 2θ position, respectively (data not shown). 
The comparison of the physical mixtures and extruded granules diffractograms in Fig.  5 
showed a decrease on the intensity of the diffractograms for all formulations.  This indicates 
that a small fraction of IBU transformed from crystalline to amorphous during the granulation 
process. In order to obtain and identify the amount of amorphous content present, our data 
was fitted to a standard diffractogram taken from the Cambridge Structural Database (CSD). 
The amorphous content was then calculated from the redistributed amount which are not 
attributed to the crystalline material. This amorphous amount was found to be <5%. The 
usage of ethanol as granulating liquid and the application of high shear mixing due to the 
three zones of kneading elements facilitated the formation of a small amorphous IBU 
fraction. This is not uncommon and was also observed when aqueous granulating liquid or 
melt granulation were used for processing of IBU (Thompson, 2015). Extruded granules were 
further placed under accelerated stability conditions for six months and as expected, changes 
on IBU physical state were observed. As shown in Fig. S1 (Suppl. Material) a slight 
recrystallization of the amorphous fraction occurred at the end of the stability period.  It has 
also been previously reported that IBU’s mobility in the presence of PEG (Zhu et al., 2010) 
affects the drug physical state. 
 
 
 
3.4 DSC analysis 
DSC thermal analysis was conducted to further investigate the IBU physical state in 
the extruded granules in comparison to the bulk substance.  DSC scans were carried out for 
the bulk materials as well.  Fig. 6a illustrates the thermal melting transitions of bulk PEG and 
IBU with endothermic peaks at 62.05
o
C (H = 168.99 J/g) and 77.79oC (H = 92.42 J/g) 
respectively. Due to its amorphous nature HPMC presented a glass transition peak at 
152.69
o
C while no thermal event was detected for DCPA. Fig. 6b shows the thermal events 
for the physical mixtures where PEG presented decreased melting endotherms varying from 
59.3 – 63.8oC while for IBU only negligible shifts at 77.5 – 78.5oC could be observed with 
melting peaks appeared broad. Further melting endotherm depression can be seen for the 
granulated formulations with PEG melting endotherms varying from 40.0 – 63.5oC and IBU 
from 69.5 – 75.3oC, respectively.  
In both cases the thermal shifts are attributed to the PEG solubilizing capacity on 
IBU, which has been demonstrated in hot melt granulation studies.  Weatherley et al., 
observed stronger depression of both PEG and IBU melting endotherms in melted granules 
due to the solubilisation of IBU in the melted polymer (Weatherley et al., 2013). As we didn't 
apply any thermal processing for the current extrusion granulation the depression of the 
melting endotherms is also attributed to a combination of factors such as a) the particle size 
reduction caused by the kneading elements (Niazi, 2007)  and b) PEG reach domains in the 
granules due to the excellent mixing of the extrusion processing.   
 
3.5 DVS analysis 
The effect of controlled moisture on the physical solid state stability of the IBU 
granules manufactured via twin screw granulation process was studied using a DVS machine. 
The moisture absorption and desorption profiles of the manufactured granules assessed and 
monitored are depicted in Fig. 7.  For this study, it is assumed that the amount of water up-
taken by various granules can be correlated to its solid-state stability via the dynamic vapour 
sorption analysis.  The presence of hydrophilic components such as HPMC and PEG along 
with the inorganic DCPA, which promotes disintegration when used in oral solid dosage 
forms, may lead to an increased amount of water absorbed. As can be seen in Fig. 7, the 
vapour sorption isotherms indicates increased amount of water uptake upon increasing the 
relative humidity (RH) at two different conditions (ambient and 40
o
C). All formulations 
presented a mass increase from 1.1 – 3.0% at 60% RH at both 25oC and 40oC temperature 
settings. After 60% RH the water sorption accelerated and the mass of the granules was 
further increased up to 6 – 7.0% at 100% RH for all three granules batches. As expected the 
desorption segments of F2, F8 and F9 exhibited a reversible process projected by the event of 
a steady water loss. All three batches showed similar DVS profiles regardless the difference 
in formulation compositions and the changes in mass at any relative humidity values higher 
than 80% RH, dropped significantly.   
The increase water sorption for the three granule batches was initially attributed to the 
composition of the formulations, which contain high amounts of hydrophilic carriers such as 
HPMC and PEG.  However, as it can be seen in Fig. 7(d), unlike other two formulations (F8 
and F9), F2 showed temperature independent mass gain as a function of water uptake. In both 
ambient and 40
o
C, F2 presented a significant mass gain when the relative humility reached 
100% RH. By examining the values of the dependent variables in Table 1 for the three 
batches carefully, it is noticed that F2 has a significant smaller particle size and higher SSA 
compared to the other two. Thus, the increased water sorption for F2 can be attributed to the 
impact of the physical properties such as particle size and SSA.   
 
3.6 In vitro dissolution studies 
One of the main targets of the extrusion granulation process was to enhance the 
dissolution rates of the water insoluble IBU. DCPA facilitates granule disintegration due to 
the rapid water uptake and HPMC has been reported to increase dissolution rates due to its 
hydrophilic nature.  Fig. 8 shows the dissolution profiles of high IBU loaded granules (40% 
w/w) for extruded formulations with the highest dissolution rates in comparison to bulk 
substance in acidic medium (pH1.2).  As it can be seen dissolution rates varied from 65 – 
80% after 120min for the extruded granules while only 10% of bulk IBU was dissolved at the 
same time. As mentioned above all independent parameters have a significant effect on the 
granule dissolution rates. However, for the formulations with the best dissolution 
performance independent variables varied from 0.33 – 1.0 DCPA/HPMC ratios, 5 – 8% PEG 
amounts and 0.25 – 0.3 L/S ratios. Since X-ray analysis showed a small amorphous fraction 
of IBU in the granules the increase dissolution rates were attributed to the drug adsorption in 
the inorganic porous network and the subsequent particle size reduction mentioned above.  In 
addition, faster dissolution rates were observed for granulated formulations with high specific 
surface area (>0.100m
2
/g), which is directly related to granule porosity.  The phenomenon is 
not uncommon and dissolution properties have found to be significantly affected by porosity 
changes of the prepared granules (Weatherley et al., 2013; Le et al., 2011) which can result in 
faster hydration rates and water sorption. This is in good agreement with the DVS analysis 
which showed higher water sorption for granules with high surface area and small particle 
size.  The accelerated stability batches (Fig. S2, Suppl. Material) presented similar dissolution 
profiles after six months without any significant changes irrespectively of the IBU 
recrystallization as mentioned above. 
4. Conclusions 
A QbD study was designed to identify the effect of formulation independent variables 
such as DCPA/Polymer ratio, binder concentration and L/S ratio on the dissolution rate, 
median particle size and specific surface area (dependent variables) of wet extruded IBU 
granules.  The DoE integration revealed that each dependent variable was significantly 
affected by the formulation parameters.  Physicochemical characterizations showed that IBU 
crystallinity was slightly affected and a small fraction turned to amorphous state, despite the 
use of ethanolic granulating liquid. The extruded granules showed uniform particle size 
distribution, excellent flowability and fast dissolution rates in acidic media due to IBU 
particles size reduction, through the granulation process, the adsorption in the porous 
inorganic excipient and the high specific surface area of the obtained granules.    
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TABLE(S) 
Table 1: DoE of extrusion granulation with DCPA/Polymer ration, binder amount (%) and 
L/S ratio as independent variables and release (%), median particle size diameter D(50) and 
specific surface area (m
2
/g) as dependent variables 
 
Process independent variables Process dependent variables 
Run 
No. 
DCPA/Polymer 
ratio 
Binder  
(%) 
L/S ratio 
 
Release (T120min) 
 (%) 
D(50) 
(µm) 
SSA  
(m
2
/g) 
F1 2.0 8.0 0.25 72.86 245.1 0.085 
F2 1.0 8.0 0.30 80.25 188.0 0.107 
F3 0.33 8.0 0.30 75.17 403.9 0.047 
F4 2.0 5.0 0.40 67.38 289.6 0.095 
F5 2.0 12.0 0.30 67.12 262.7 0.068 
F6 1.0 8.0 0.40 68.75 1033.1 0.024 
F7 0.33 12.0 0.40 71.03 583.3 0.072 
F8 0.33 5.0 0.25 76.66 287.2 0.062 
F9 1.0 5.0 0.30 64.89 251.9  0.032 
F10 1.0 8.0 0.30 79.90  200.5 0.101 
F11 1.0 12.0 0.25 66.23 327.0 0.068 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figures caption list 
 
Fig. 1 Image of the twin – screw configuration used for the extrusion granulation process. 
Fig. 2 Response surface plots of IBU release, specific surface area and particle size 
distribution dependent variables 
Fig. 3 SEM images of a) bulk IBU, b) F2 granules  (DCPA/Polymer 1.0, Binder 8.0%,  L/S 
ratio 0.30) and c) F10 granules (DCPA/Polymer 1.0, Binder 8.0%,  L/S ratio 0.30) 
Fig. 4 Laser diffraction particle size analysis of various extruded granules F2 
(DCPA/Polymer 1.0, Binder 8.0%,  L/S ratio 0.30), F9 (DCPA/Polymer 1.0, Binder 
5.0%,  L/S ratio 0.30) and F11 (DCPA/Polymer 1.0, Binder 12.0%,  L/S ratio 0.25) 
Fig. 5 XRPD diffractograms of bulk IBU (inset), physical mixture (red) and extruded 
granules (purple). 
Fig. 6 DSC thermographs of a) bulk DCPA, HPMC, IBU and b) physical mixtures and 
extruded granules. 
Fig. 7 DVS analysis of water sorption and desorption of F2 (DCPA/Polymer 1.0, Binder 
8.0%, L/S ratio 0.30), F8 (DCPA/Polymer 0.33, Binder 5.0%,  L/S ratio 0.25) and F9 
(DCPA/Polymer 1.0, Binder 5.0%,  L/S ratio 0.30) extruded granules. 
Fig. 8 In vitro dissolution studies of bulk IBU and extruded granules (n=3, 37
o
C, 100 rpm). 
 









